Avalo Therapeutics Inc Capital Reinvestment Ratio

Latest as of September 2022: 0.01x

Avalo Therapeutics Inc capital reinvestment ratio. Avalo Therapeutics Inc (AVTX) has a Capital Reinvestment Ratio of 0.01x as of September 2022, meaning it reinvests 0% of its operating cash flow ($5.73 Million) in capital expenditures ($39.00K). Check Avalo Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$5.73 Million

USD

Capital Expenditures

$39.00K

USD

Data as of

Sep 2022

Most recent filing

Capital Reinvestment Ratio of Avalo Therapeutics Inc (2017–2017)

Capital reinvestment ratio of Avalo Therapeutics Inc from 2017 to 2017. This chart tracks Avalo Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of Avalo Therapeutics Inc to track the company's year-over-year net asset growth rate.

Avalo Therapeutics Inc Capital Reinvestment Ratio by Year (2017–2017)

Avalo Therapeutics Inc capital reinvestment ratio by year from 2017 to 2017. For the full cash flow conversion analysis, see Avalo Therapeutics Inc (AVTX) cash conversion ratio.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2017	0.00x	$12.52 Million	$23.32K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow